Corimmun Overview

  • Founded
  • 2006
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Corimmun General Information


Developer of therapeutics for the treatment of cardiovascular diseases. The company produces medication for cardiovascular diseases with unmet medical need.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Lochhamer Street 29
  • Rückgebäude
  • 82152 Martinsried
  • Germany
+49 00000000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Corimmun Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 28-Jun-2012 000.00 Completed Generating Revenue
4. Early Stage VC (Series B) 01-Oct-2010 00.00 000.00 Completed Generating Revenue
3. Grant 05-Jul-2010 00.000 00.000 Completed
2. Early Stage VC (Series A) 22-Aug-2008 $7.59M $8.48M Completed Product Development
1. Seed Round 01-Jan-2007 $897K $897K Completed Startup
To view Corimmun’s complete valuation and funding history, request access »

Corimmun Executive Team (3)

Name Title Board Seat Contact Info
Götz Münch Co-Founder and Chief Executive Officer
Martin Ungerer Chief Medical Officer and Co-Founder
You’re viewing 2 of 3 executive team members. Get the full list »

Corimmun Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bayern Kapital Venture Capital Minority 000 0000 000000 0
BioM Biotech Cluster Development Accelerator/Incubator Minority 000 0000 000000 0
Global Chance Fund Venture Capital Minority 000 0000 000000 0
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
KfW Group Investment Bank Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Corimmun Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Jan-2007 000000000 Other Healthcare Technology Systems
To view Corimmun’s complete investments history, request access »